TNFRSF1A and cancer: Overall, as these clinical trials have been performed under unfavorable conditions – the cohort patients were at the most advanced stages of disease, and their immune system has been already manipulated by repeated therapies – their findings suggest that TNFα-TNFR-directed treatments may be effective in cancer.